The Regulation and Interactions of the Hypoxia Inducible Factor Pathway in Carcinogenesis and Potential Cancer Therapeutic Strategies

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"The Regulation and Interactions of the Hypoxia Inducible Factor Pathway in Carcinogenesis and Potential Cancer Therapeutic Strategies"
written by Niraj Shenoy, Makardhwaj Shrivastava, Vineeth Sukrithan, Dimitra Papaspyridi, Karine Darbinyan,
published by Journal of Cancer Therapy, Vol.6 No.6, 2015

has been cited by the following article(s):

[1]	Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors
	Journal of Biomolecular …, 2022

[2]	Understanding and targeting epigenetic dysregulation, aberrant metabolism, and immune evasion in cancer with ascorbic acid
	2020

[3]	HIF1α is not a target of 14q deletion in clear cell renal cancer
	2020

[4]	Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma
	2018

[5]	Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
	Chinese Journal of Cancer Research, 2017

[6]	Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective
	Medicinal research reviews, 2017

[7]	Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors—a major reason for enhanced chemosensitivity?
	Chinese Journal of Cancer Research, 2017

[8]	Sequential pathogenesis of metastatic VHL mutant clear cell Renal cell carcinoma-putting it together with a translational perspective
	Annals of Oncology, 2016

[9]	Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
	2016

[1]	Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors Journal of Biomolecular Structure and Dynamics, 2023 DOI:10.1080/07391102.2022.2051745

[2]	Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors Journal of Biomolecular Structure and Dynamics, 2022 DOI:10.1080/07391102.2022.2051745

[3]	HIF1α is not a target of 14q deletion in clear cell renal cancer Scientific Reports, 2020 DOI:10.1038/s41598-020-74631-7

[4]	HIF1α is not a target of 14q deletion in clear cell renal cancer Scientific Reports, 2020 DOI:10.1038/s41598-020-74631-7

[5]	Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective Medicinal Research Reviews, 2018 DOI:10.1002/med.21477

[6]	Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective Medicinal Research Reviews, 2017 DOI:10.1002/med.21477

[7]	Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective Annals of Oncology, 2016 DOI:10.1093/annonc/mdw241

Follow SCIRP